Which has stronger earnings and valuation, AEMD or AMIX?

Autonomix Medical is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aethlon Medical N/A N/A -$7.15M -$34.97 N/A Autonomix Medical N/A N/A -$16.72M -$41.57 N/A

Is AEMD or AMIX more profitable?

Aethlon Medical's return on equity of -123.08% beat Autonomix Medical's return on equity. Company Net Margins Return on Equity Return on Assets Aethlon Medical N/A -123.08% -99.28% Autonomix Medical N/A -267.73% -216.75%

Does the media refer more to AEMD or AMIX?

In the previous week, Aethlon Medical and Aethlon Medical both had 4 articles in the media. Autonomix Medical's average media sentiment score of 0.84 beat Aethlon Medical's score of 0.50 indicating that Autonomix Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aethlon Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Autonomix Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer VSA or AEMD?

Aethlon Medical has a consensus price target of $1.50, suggesting a potential upside of 0.81%. Given Aethlon Medical's stronger consensus rating and higher probable upside, analysts plainly believe Aethlon Medical is more favorable than TCTM Kids IT Education. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TCTM Kids IT Education 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Aethlon Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Is VSA or AEMD more profitable?

TCTM Kids IT Education's return on equity of 0.00% beat Aethlon Medical's return on equity. Company Net Margins Return on Equity Return on Assets TCTM Kids IT Education N/A N/A N/A Aethlon Medical N/A -123.08% -99.28%

Do analysts prefer ZYXI or AEMD?

Aethlon Medical has a consensus target price of $1.50, suggesting a potential upside of 0.81%. Given Aethlon Medical's stronger consensus rating and higher probable upside, analysts plainly believe Aethlon Medical is more favorable than Zynex. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zynex 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Aethlon Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Is ZYXI or AEMD more profitable?

Aethlon Medical has a net margin of 0.00% compared to Zynex's net margin of -68.35%. Aethlon Medical's return on equity of -123.08% beat Zynex's return on equity. Company Net Margins Return on Equity Return on Assets Zynex -68.35% -804.30% -36.67% Aethlon Medical N/A -123.08% -99.28%

Do analysts rate BJDX or AEMD?

Aethlon Medical has a consensus target price of $1.50, suggesting a potential upside of 0.81%. Given Aethlon Medical's stronger consensus rating and higher possible upside, analysts clearly believe Aethlon Medical is more favorable than Bluejay Diagnostics. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bluejay Diagnostics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Aethlon Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Which has better valuation & earnings, BJDX or AEMD?

Bluejay Diagnostics is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Bluejay Diagnostics N/A N/A -$6.85M -$7.11 N/A Aethlon Medical N/A N/A -$7.15M -$34.97 N/A

Is BJDX or AEMD more profitable?

Aethlon Medical's return on equity of -123.08% beat Bluejay Diagnostics' return on equity. Company Net Margins Return on Equity Return on Assets Bluejay Diagnostics N/A -125.00% -99.79% Aethlon Medical N/A -123.08% -99.28%

Does the media favor BJDX or AEMD?

In the previous week, Aethlon Medical had 1 more articles in the media than Bluejay Diagnostics. MarketBeat recorded 4 mentions for Aethlon Medical and 3 mentions for Bluejay Diagnostics. Aethlon Medical's average media sentiment score of 0.50 beat Bluejay Diagnostics' score of 0.21 indicating that Aethlon Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bluejay Diagnostics 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Aethlon Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend AEMD or FEED?

Aethlon Medical currently has a consensus target price of $1.50, indicating a potential upside of 0.81%. Given Aethlon Medical's stronger consensus rating and higher probable upside, research analysts clearly believe Aethlon Medical is more favorable than Nanovibronix. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aethlon Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Nanovibronix 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media refer more to AEMD or FEED?

In the previous week, Nanovibronix had 3 more articles in the media than Aethlon Medical. MarketBeat recorded 7 mentions for Nanovibronix and 4 mentions for Aethlon Medical. Aethlon Medical's average media sentiment score of 0.50 beat Nanovibronix's score of 0.38 indicating that Aethlon Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aethlon Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Nanovibronix 0 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Aethlon Medical (AEMD) Competitors

$1.49 +0.02 (+1.22%)

As of 12:13 PM Eastern

Compare

AEMD vs. AMIX, VSA, ZYXI, BJDX, and FEED

Should you buy Aethlon Medical stock or one of its competitors? Aethlon Medical's main competitors and comparable companies include Autonomix Medical (AMIX), TCTM Kids IT Education (VSA), Zynex (ZYXI), Bluejay Diagnostics (BJDX), and Nanovibronix (FEED). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Aethlon Medical compare to Autonomix Medical?

Aethlon Medical (NASDAQ:AEMD) and Autonomix Medical (NASDAQ:AMIX) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, valuation, earnings, profitability, media sentiment and analyst recommendations.

Aethlon Medical's return on equity of -123.08% beat Autonomix Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aethlon Medical	N/A	-123.08%	-99.28%
Autonomix Medical	N/A	-267.73%	-216.75%

2.0% of Aethlon Medical shares are owned by institutional investors. Comparatively, 10.8% of Autonomix Medical shares are owned by institutional investors. 0.6% of Aethlon Medical shares are owned by insiders. Comparatively, 6.2% of Autonomix Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Aethlon Medical and Aethlon Medical both had 4 articles in the media. Autonomix Medical's average media sentiment score of 0.84 beat Aethlon Medical's score of 0.50 indicating that Autonomix Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aethlon Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Autonomix Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Aethlon Medical has a beta of 1.4, indicating that its share price is 40% more volatile than the broader market. Comparatively, Autonomix Medical has a beta of -1, indicating that its share price is 200% less volatile than the broader market.

Aethlon Medical presently has a consensus target price of $1.50, indicating a potential upside of 0.81%. Autonomix Medical has a consensus target price of $42.00, indicating a potential upside of 916.95%. Given Autonomix Medical's stronger consensus rating and higher possible upside, analysts plainly believe Autonomix Medical is more favorable than Aethlon Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Autonomix Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Autonomix Medical is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aethlon Medical	N/A	N/A	-$7.15M	-$34.97	N/A
Autonomix Medical	N/A	N/A	-$16.72M	-$41.57	N/A

Summary

Aethlon Medical and Autonomix Medical tied by winning 6 of the 12 factors compared between the two stocks.

How does Aethlon Medical compare to TCTM Kids IT Education?

TCTM Kids IT Education (NASDAQ:VSA) and Aethlon Medical (NASDAQ:AEMD) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, institutional ownership, risk, media sentiment, dividends, analyst recommendations and profitability.

Aethlon Medical has a consensus price target of $1.50, suggesting a potential upside of 0.81%. Given Aethlon Medical's stronger consensus rating and higher probable upside, analysts plainly believe Aethlon Medical is more favorable than TCTM Kids IT Education.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TCTM Kids IT Education	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

TCTM Kids IT Education has a beta of 0.56, meaning that its share price is 44% less volatile than the broader market. Comparatively, Aethlon Medical has a beta of 1.4, meaning that its share price is 40% more volatile than the broader market.

49.8% of TCTM Kids IT Education shares are held by institutional investors. Comparatively, 2.0% of Aethlon Medical shares are held by institutional investors. 32.9% of TCTM Kids IT Education shares are held by company insiders. Comparatively, 0.6% of Aethlon Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

TCTM Kids IT Education's return on equity of 0.00% beat Aethlon Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TCTM Kids IT Education	N/A	N/A	N/A
Aethlon Medical	N/A	-123.08%	-99.28%

In the previous week, Aethlon Medical had 2 more articles in the media than TCTM Kids IT Education. MarketBeat recorded 4 mentions for Aethlon Medical and 2 mentions for TCTM Kids IT Education. TCTM Kids IT Education's average media sentiment score of 1.44 beat Aethlon Medical's score of 0.50 indicating that TCTM Kids IT Education is being referred to more favorably in the media.

Company	Overall Sentiment
TCTM Kids IT Education	Positive
Aethlon Medical	Neutral

TCTM Kids IT Education has higher revenue and earnings than Aethlon Medical. Aethlon Medical is trading at a lower price-to-earnings ratio than TCTM Kids IT Education, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TCTM Kids IT Education	$150K	21.63	$245.80M	$45.00	0.06
Aethlon Medical	N/A	N/A	-$7.15M	-$34.97	N/A

Summary

TCTM Kids IT Education beats Aethlon Medical on 9 of the 13 factors compared between the two stocks.

How does Aethlon Medical compare to Zynex?

Zynex (NASDAQ:ZYXI) and Aethlon Medical (NASDAQ:AEMD) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, valuation, earnings, institutional ownership, risk, analyst recommendations and profitability.

Zynex has a beta of 0.99, meaning that its share price is 1% less volatile than the broader market. Comparatively, Aethlon Medical has a beta of 1.4, meaning that its share price is 40% more volatile than the broader market.

Zynex has higher revenue and earnings than Aethlon Medical. Zynex is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zynex	$108.20M	0.04	$2.99M	-$2.43	N/A
Aethlon Medical	N/A	N/A	-$7.15M	-$34.97	N/A

29.7% of Zynex shares are held by institutional investors. Comparatively, 2.0% of Aethlon Medical shares are held by institutional investors. 49.3% of Zynex shares are held by insiders. Comparatively, 0.6% of Aethlon Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Aethlon Medical has a consensus target price of $1.50, suggesting a potential upside of 0.81%. Given Aethlon Medical's stronger consensus rating and higher probable upside, analysts plainly believe Aethlon Medical is more favorable than Zynex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zynex	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Aethlon Medical has a net margin of 0.00% compared to Zynex's net margin of -68.35%. Aethlon Medical's return on equity of -123.08% beat Zynex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zynex	-68.35%	-804.30%	-36.67%
Aethlon Medical	N/A	-123.08%	-99.28%

In the previous week, Aethlon Medical had 4 more articles in the media than Zynex. MarketBeat recorded 4 mentions for Aethlon Medical and 0 mentions for Zynex. Aethlon Medical's average media sentiment score of 0.50 beat Zynex's score of 0.00 indicating that Aethlon Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Zynex	Neutral
Aethlon Medical	Neutral

Summary

Aethlon Medical beats Zynex on 8 of the 14 factors compared between the two stocks.

How does Aethlon Medical compare to Bluejay Diagnostics?

Bluejay Diagnostics (NASDAQ:BJDX) and Aethlon Medical (NASDAQ:AEMD) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, valuation, media sentiment, analyst recommendations, dividends and profitability.

18.5% of Bluejay Diagnostics shares are held by institutional investors. Comparatively, 2.0% of Aethlon Medical shares are held by institutional investors. 6.1% of Bluejay Diagnostics shares are held by company insiders. Comparatively, 0.6% of Aethlon Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Bluejay Diagnostics is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bluejay Diagnostics	N/A	N/A	-$6.85M	-$7.11	N/A
Aethlon Medical	N/A	N/A	-$7.15M	-$34.97	N/A

Aethlon Medical has a consensus target price of $1.50, suggesting a potential upside of 0.81%. Given Aethlon Medical's stronger consensus rating and higher possible upside, analysts clearly believe Aethlon Medical is more favorable than Bluejay Diagnostics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bluejay Diagnostics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Bluejay Diagnostics has a beta of 0.91, meaning that its stock price is 9% less volatile than the broader market. Comparatively, Aethlon Medical has a beta of 1.4, meaning that its stock price is 40% more volatile than the broader market.

In the previous week, Aethlon Medical had 1 more articles in the media than Bluejay Diagnostics. MarketBeat recorded 4 mentions for Aethlon Medical and 3 mentions for Bluejay Diagnostics. Aethlon Medical's average media sentiment score of 0.50 beat Bluejay Diagnostics' score of 0.21 indicating that Aethlon Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bluejay Diagnostics	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Aethlon Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Aethlon Medical's return on equity of -123.08% beat Bluejay Diagnostics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bluejay Diagnostics	N/A	-125.00%	-99.79%
Aethlon Medical	N/A	-123.08%	-99.28%

Summary

Aethlon Medical beats Bluejay Diagnostics on 8 of the 12 factors compared between the two stocks.

How does Aethlon Medical compare to Nanovibronix?

Aethlon Medical (NASDAQ:AEMD) and Nanovibronix (NASDAQ:FEED) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings, analyst recommendations and media sentiment.

Aethlon Medical has a beta of 1.4, meaning that its stock price is 40% more volatile than the broader market. Comparatively, Nanovibronix has a beta of 1.38, meaning that its stock price is 38% more volatile than the broader market.

In the previous week, Nanovibronix had 3 more articles in the media than Aethlon Medical. MarketBeat recorded 7 mentions for Nanovibronix and 4 mentions for Aethlon Medical. Aethlon Medical's average media sentiment score of 0.50 beat Nanovibronix's score of 0.38 indicating that Aethlon Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aethlon Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Nanovibronix	0 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Aethlon Medical has a net margin of 0.00% compared to Nanovibronix's net margin of -1,093.61%. Nanovibronix's return on equity of -60.73% beat Aethlon Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aethlon Medical	N/A	-123.08%	-99.28%
Nanovibronix	-1,093.61%	-60.73%	-48.48%

Aethlon Medical has higher earnings, but lower revenue than Nanovibronix. Aethlon Medical is trading at a lower price-to-earnings ratio than Nanovibronix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aethlon Medical	N/A	N/A	-$7.15M	-$34.97	N/A
Nanovibronix	$2.55M	0.25	-$18.18M	-$117.28	N/A

Aethlon Medical currently has a consensus target price of $1.50, indicating a potential upside of 0.81%. Given Aethlon Medical's stronger consensus rating and higher probable upside, research analysts clearly believe Aethlon Medical is more favorable than Nanovibronix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Nanovibronix	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

2.0% of Aethlon Medical shares are owned by institutional investors. Comparatively, 16.4% of Nanovibronix shares are owned by institutional investors. 0.6% of Aethlon Medical shares are owned by insiders. Comparatively, 12.2% of Nanovibronix shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Aethlon Medical and Nanovibronix tied by winning 7 of the 14 factors compared between the two stocks.

Get Aethlon Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AEMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AEMD vs. The Competition

Export

Metric	Aethlon Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.06M	$5.51B	$7.23B	$15.01B
Dividend Yield	N/A	1.79%	2.57%	11.71%
P/E Ratio	-0.04	25.21	273.94	25.50
Price / Sales	N/A	68.14	699.86	113.23
Price / Cash	N/A	32.78	77.71	51.48
Price / Book	0.10	5.99	10.44	6.27
Net Income	-$7.15M	$150.94M	$3.49B	$358.21M
7 Day Performance	-11.95%	-0.81%	0.02%	0.19%
1 Month Performance	-47.42%	-3.50%	0.07%	-3.23%
1 Year Performance	-96.06%	9.00%	19.31%	6.53%

Aethlon Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AEMD Aethlon Medical	0.9606 of 5 stars	$1.49 +1.2%	$1.50 +0.8%	-96.0%	$1.06M	N/A	N/A	10	News Coverage Gap Down
AMIX Autonomix Medical	2.7986 of 5 stars	$4.58 -0.2%	$42.00 +817.0%	-82.1%	$4.46M	N/A	N/A	1	Analyst Downgrade Short Interest Decrease
VSA TCTM Kids IT Education	1.8651 of 5 stars	$3.01 -8.2%	N/A	-99.8%	$4.01M	$150K	0.07	4,142	Positive News Short Interest Decrease
ZYXI Zynex	N/A	$0.13 flat	N/A	N/A	$3.80M	$108.20M	N/A	770
BJDX Bluejay Diagnostics	0.9562 of 5 stars	$1.03 +23.7%	N/A	-86.2%	$3.72M	N/A	N/A	9	Analyst Downgrade High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:AEMD) was last updated on 9/16/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Aethlon Medical (AEMD) Competitors

AEMD vs. AMIX, VSA, ZYXI, BJDX, and FEED

How does Aethlon Medical compare to Autonomix Medical?

Summary

How does Aethlon Medical compare to TCTM Kids IT Education?

Summary

How does Aethlon Medical compare to Zynex?

Summary

How does Aethlon Medical compare to Bluejay Diagnostics?

Summary

How does Aethlon Medical compare to Nanovibronix?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AEMD vs. The Competition

Aethlon Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Aethlon Medical (AEMD) Competitors

AEMD vs. AMIX, VSA, ZYXI, BJDX, and FEED

How does Aethlon Medical compare to Autonomix Medical?

Is AEMD or AMIX more profitable?

Do insiders and institutionals believe in AEMD or AMIX?

Does the media refer more to AEMD or AMIX?

Which has more risk and volatility, AEMD or AMIX?

Do analysts prefer AEMD or AMIX?

Which has stronger earnings and valuation, AEMD or AMIX?

Summary

How does Aethlon Medical compare to TCTM Kids IT Education?

Do analysts prefer VSA or AEMD?

Which has more risk & volatility, VSA or AEMD?

Do insiders & institutionals believe in VSA or AEMD?

Is VSA or AEMD more profitable?

Does the media favor VSA or AEMD?

Which has preferable valuation and earnings, VSA or AEMD?

Summary

How does Aethlon Medical compare to Zynex?

Which has more risk and volatility, ZYXI or AEMD?

Which has stronger earnings & valuation, ZYXI or AEMD?

Do insiders and institutionals believe in ZYXI or AEMD?

Do analysts prefer ZYXI or AEMD?

Is ZYXI or AEMD more profitable?

Does the media favor ZYXI or AEMD?

Summary

How does Aethlon Medical compare to Bluejay Diagnostics?

Do institutionals & insiders believe in BJDX or AEMD?

Which has better valuation & earnings, BJDX or AEMD?

Do analysts rate BJDX or AEMD?

Which has more volatility and risk, BJDX or AEMD?

Does the media favor BJDX or AEMD?

Is BJDX or AEMD more profitable?

Summary

How does Aethlon Medical compare to Nanovibronix?

Which has more risk & volatility, AEMD or FEED?

Does the media refer more to AEMD or FEED?

Is AEMD or FEED more profitable?

Which has stronger earnings and valuation, AEMD or FEED?

Do analysts recommend AEMD or FEED?

Do insiders and institutionals believe in AEMD or FEED?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AEMD vs. The Competition

Aethlon Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools